n,n-dimethylarginine has been researched along with Coronary Disease in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 21 (63.64) | 29.6817 |
| 2010's | 12 (36.36) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, KJ; Chen, Z; Gao, ZY; Shang, QH; Shi, DZ; Xu, H; Yu, CA | 1 |
| Borzak, S; DeMets, D; Hennekens, CH; Hetzel, S; Schneider, R; Schneider, W; Schröder, H; Serebruany, V | 1 |
| Baghestani, AR; Hosseini, S; Miri, R; Mokhtari, Z; Nasrollahzadeh, J; Rismanchi, M; Zahedirad, M | 1 |
| Chang, P; Cooke, JP; Ghebremariam, YT; Khan, F; Leeper, NJ; Nead, KT; Shah, NH; Thakker, RN | 1 |
| Huang, S; Jiang, X; Peng, W; Shao, K; Tang, Y; Xia, L; Zou, D | 1 |
| Surdacki, A | 1 |
| Bode-Böger, SM; Goette, A; Jentsch-Ullrich, K; Lendeckel, U; Martens-Lobenhoffer, J; Scalera, F; Wolfram, O | 1 |
| Ajtay, Z; Awiszus, F; Bode-Böger, SM; Cziráki, A; Horváth, I; Martens-Lobenhoffer, J; Papp, L; Scalera, F; Sulyok, E; Szabo, C | 1 |
| Cao, Y; Ouyang, M; Xiao, L; Yang, K; Zhang, Z | 1 |
| Ilic, MD; Ilic, S; Kocic, G; Lazarevic, G; Pavlovic, R; Stefanovic, V | 1 |
| Boehm, BO; Drechsler, C; Kielstein, JT; März, W; Meinitzer, A; Pilz, S; Ritz, E; Winkelmann, BR | 1 |
| SHAO, JM; WANG, DW; YOU, L; ZHANG, L; ZHAO, CX | 1 |
| Atzeni, F; Battellino, M; Boccassini, L; De Gennaro Colonna, V; Marchesoni, A; Sarzi-Puttini, P; Sitia, S; Tomasoni, L; Turiel, M | 1 |
| Böger, R; Breitling, LP; Brenner, H; Koenig, W; Maas, R; Rothenbacher, D; Schwedhelm, E; Siegerink, B; Vossen, CY | 1 |
| McGrath, BP; Teede, HJ | 1 |
| Fujita, M; Hori, M; Kitakaze, M; Nanto, S; Node, K | 1 |
| Ding, YA; Lee, WS; Lin, SJ; Lu, TM; Tai, HC | 1 |
| Isomustajärvi, M; Laakso, J; Laaksonen, R; Lakka, TA; Lehtimäki, T; Päivä, H; Ruokonen, I; Salonen, JT; Valkonen, VP | 1 |
| Böger, RH; Hanefeld, C; Mügge, A | 1 |
| Böger, RH | 1 |
| Hayashida, Y; Morishita, T; Nakashima, Y; Nakata, S; Sasaguri, Y; Suda, O; Tasaki, H; Toyohira, Y; Tsujimoto, T; Tsutsui, M; Ueno, S; Ueta, Y; Yanagihara, N | 1 |
| Nishio, I; Tsuda, K | 1 |
| Arnesen, H; Eid, HM; Hjerkinn, EM; Lyberg, T; Seljeflot, I | 1 |
| Naidoo, D; Salonikas, C; Sim, AS; Wang, J; Wang, XL; Wilcken, DE | 1 |
| Bickel, C; Blankenberg, S; Cambien, F; Espinola-Klein, C; Jachmann, N; Lackner, KJ; Lubos, E; Münzel, T; Peetz, D; Post, F; Rupprecht, HJ; Schnabel, R; Tiret, L | 1 |
| Bartling, A; Böger, RH; Daniel, WG; Goudeva, L; Hanefeld, C; Kusus, M; Lenzen, H; Maas, R; Maisch, B; Mügge, A; Osterziel, KJ; Schmidt-Lucke, C; Schulze, F; Schwedhelm, E; Simon, BC; Streichert, T; Strödter, D; Tillmanns, H | 1 |
| Karu, I; Starkopf, J; Zilmer, K; Zilmer, M | 1 |
| Anderson, JL; Bair, TL; Carlquist, JF; Horne, BD; Kushnir, MM; May, HT; Muhlestein, JB; Nielson, R; Pasquali, M; Roberts, WL; Rockwood, AL; Schwarz, EL | 1 |
| Boehm, BO; Halwachs-Baumann, G; März, W; Meinitzer, A; Seelhorst, U; Wellnitz, B; Winkelmann, BR | 1 |
| Baumert, J; Böger, RH; Hamraz, K; Koenig, W; Löwel, H; Maas, R; Schulze, F; Schwedhelm, E | 1 |
| Branzi, A; Coccolo, F; Cooke, JP; Fallani, F; Ferrara, R; Grigioni, F; Lewis, DB; Magelli, C; Magnani, G; Mocarski, ES; Potena, L; Valantine, HA | 1 |
| Kenemans, P; Teerlink, T; van der Mooren, MJ; Verhoeven, MO; Zuijdgeest-van Leeuwen, SD | 1 |
| Kiani, AN; Mahoney, JA; Petri, M | 1 |
6 review(s) available for n,n-dimethylarginine and Coronary Disease
| Article | Year |
|---|---|
L-arginine analogs--inactive markers or active agents in atherogenesis?
Topics: Arginine; Atherosclerosis; Biomarkers; Coronary Disease; Endothelium, Vascular; Humans; Inflammation; Nitric Oxide; Oxidative Stress | 2008 |
Cardiovascular involvement in psoriatic arthritis.
Topics: Antirheumatic Agents; Arginine; Arthritis, Psoriatic; Coronary Circulation; Coronary Disease; Cytokines; Heart Diseases; Humans; Inflammation; Microcirculation; Risk Factors; Tumor Necrosis Factor-alpha | 2011 |
[ADMA (asymmetric dimethyl arginine) and coronary artery disease].
Topics: Animals; Arginine; Coronary Disease; Humans | 2003 |
Plasma concentration of asymmetric dimethylarginine and the risk of coronary heart disease: rationale and design of the multicenter CARDIAC study.
Topics: Arginine; Coronary Disease; Endothelium, Vascular; Enzyme Inhibitors; Follow-Up Studies; Humans; Nitric Oxide; Prospective Studies; Risk Factors; Vasodilation | 2003 |
[Asymmetrical methylarginine (ADMA) as a cardiovascular risk factor: epidemiological and prospective data].
Topics: Adult; Aged; Aged, 80 and over; Animals; Arginine; Arteriosclerosis; Biomarkers; Cardiovascular Diseases; Case-Control Studies; Cells, Cultured; Child; Coronary Disease; Diabetes Mellitus, Type 2; Disease Models, Animal; Endothelial Cells; Enzyme-Linked Immunosorbent Assay; Female; Free Radicals; Humans; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Multicenter Studies as Topic; Multivariate Analysis; Nitric Oxide Synthase; Oxidative Stress; Pre-Eclampsia; Pregnancy; Prospective Studies; Rabbits; Regression Analysis; Renal Dialysis; Risk Factors; Stroke | 2004 |
[Coronary allograft vasculopathy: pathophysiological interaction between the immune system, infections and metabolic syndrome].
Topics: Animals; Arginine; Clinical Trials as Topic; Coronary Disease; Cytomegalovirus Infections; Disease Models, Animal; Endothelium, Vascular; Graft Rejection; Graft Survival; Heart Transplantation; Humans; Hypolipidemic Agents; Immunosuppression Therapy; Immunosuppressive Agents; Metabolic Syndrome; Quality of Life; Risk Assessment; Risk Factors; Rodentia; Stents; Time Factors | 2007 |
7 trial(s) available for n,n-dimethylarginine and Coronary Disease
| Article | Year |
|---|---|
Aspirin increases nitric oxide formation in chronic stable coronary disease.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Arginine; Aspirin; Biomarkers; Cardiovascular Agents; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Down-Regulation; Female; Heme Oxygenase-1; Humans; Male; Middle Aged; Nitric Oxide; Platelet Aggregation Inhibitors; Tablets, Enteric-Coated; Up-Regulation | 2013 |
Proton pump inhibitors and vascular function: A prospective cross-over pilot study.
Topics: Administration, Oral; Adult; Arginine; Biomarkers; California; Coronary Disease; Cross-Over Studies; Drug Administration Schedule; Female; Humans; Lansoprazole; Male; Middle Aged; Pilot Projects; Predictive Value of Tests; Prospective Studies; Proton Pump Inhibitors; Reproducibility of Results; Risk Assessment; Time Factors; Upper Extremity; Vasodilation; Young Adult | 2015 |
The effects of G-CSF-induced mobilization of progenitor cells are limited by ADMA.
Topics: Aged; Aged, 80 and over; Angina Pectoris; Antioxidants; Arginine; Cells, Cultured; Chromans; Coronary Disease; Endothelial Cells; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Humans; Leukocytosis; Male; Middle Aged; Oxidative Stress; Peroxidase; Umbilical Veins | 2010 |
Symmetrical and asymmetrical dimethylarginine as predictors for mortality in patients referred for coronary angiography: the Ludwigshafen Risk and Cardiovascular Health study.
Topics: Aged; Arginine; Biomarkers; Cardiovascular Diseases; Coronary Angiography; Coronary Disease; Female; Humans; Linear Models; Male; Middle Aged; Mortality; Predictive Value of Tests; Prognosis; Renal Insufficiency; Risk Factors | 2011 |
Asymmetrical dimethylarginine (ADMA) and risk of acute coronary events. Does statin treatment influence plasma ADMA levels?
Topics: Acute Disease; Adult; Aged; Arginine; Atorvastatin; Biomarkers; Blood Glucose; Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Double-Blind Method; Endothelium, Vascular; Enzyme Inhibitors; Female; Finland; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Male; Middle Aged; Prospective Studies; Pyrroles; Risk Factors; Simvastatin; Statistics as Topic; Triglycerides | 2003 |
Changes of plasma asymmetric dimethylarginine levels after coronary artery bypass grafting.
Topics: Arginine; Cardiopulmonary Bypass; Coronary Artery Bypass; Coronary Disease; Female; Heart Arrest, Induced; Humans; Hyperoxia; Male; Middle Aged; Myocardium; Postoperative Period; Time Factors | 2006 |
Effects of a supplement containing isoflavones and Actaea racemosa L. on asymmetric dimethylarginine, lipids, and C-reactive protein in menopausal women.
Topics: Aged; Arginine; C-Reactive Protein; Cholesterol, LDL; Cimicifuga; Coronary Disease; Double-Blind Method; Female; Humans; Isoflavones; Lipids; Menopause; Sample Size | 2007 |
20 other study(ies) available for n,n-dimethylarginine and Coronary Disease
| Article | Year |
|---|---|
Asymmetric Dimethylarginine Predicts One-year Recurrent Cardiovascular Events: Potential Biomarker of "Toxin Syndrome" in Coronary Heart Disease.
Topics: Arginine; Biomarkers; Coronary Disease; Humans; Odds Ratio; Recurrence; Risk Factors; ROC Curve; Syndrome | 2019 |
Relationship between Dietary Approaches to Stop Hypertension score and Alternative Healthy Eating Index score with plasma asymmetrical dimethylarginine levels in patients referring for coronary angiography.
Topics: Aged; Arginine; Coronary Angiography; Coronary Disease; Coronary Stenosis; Cross-Sectional Studies; Diet; Energy Intake; Female; Health Promotion; Humans; Hypertension; Iran; Male; Middle Aged | 2015 |
The prediction roles of asymmetric dimethyl-arginine, adiponectin and apelin for macroangiopathy in patients with impaired glucose regulation.
Topics: Adiponectin; Aged; Apelin; Arginine; Atherosclerosis; Blood Glucose; Coronary Disease; Female; Glucose Intolerance; Glucose Tolerance Test; Humans; Insulin Resistance; Intercellular Signaling Peptides and Proteins; Male; Middle Aged; Prediabetic State; Prognosis | 2016 |
Stent placement in patients with coronary heart disease decreases plasma levels of the endogenous nitric oxide synthase inhibitor ADMA.
Topics: Aged; Arginine; Cardiovascular Surgical Procedures; Case-Control Studies; Coronary Disease; Down-Regulation; Enzyme Inhibitors; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nitric Oxide Synthase; Stents; Time Factors | 2009 |
Correlation between plasma asymmetric dimethylarginine and different types of coronary heart disease.
Topics: Acute Coronary Syndrome; Aged; Angina Pectoris; Arginine; Biomarkers; Coronary Disease; Female; Humans; Male; Middle Aged; Nitric Oxide; von Willebrand Factor | 2010 |
Impact of reversible myocardial ischaemia on nitric oxide and asymmetric dimethylarginine production in patients with high risk for coronary heart disease.
Topics: Arginine; Coronary Disease; Diabetes Complications; Exercise Tolerance; Female; Humans; Male; Middle Aged; Nitric Oxide; Risk Factors; Ultrasonography | 2010 |
[Plasma asymmetric dimethylarginine and cystatin C levels in patients with coronary artery disease].
Topics: Aged; Arginine; Case-Control Studies; Coronary Disease; Cystatin C; Female; Humans; Male; Middle Aged | 2010 |
Asymmetric and symmetric dimethylarginine and risk of secondary cardiovascular disease events and mortality in patients with stable coronary heart disease: the KAROLA follow-up study.
Topics: Aged; Arginine; Biomarkers; Cause of Death; Chromatography, Liquid; Coronary Disease; Female; Follow-Up Studies; Germany; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Recurrence; Risk Assessment; Risk Factors; Tandem Mass Spectrometry; Time Factors | 2013 |
Oestrogen and the cardiovascular system.
Topics: Arginine; Cardiovascular Physiological Phenomena; Coronary Disease; Endothelium, Vascular; Estrogens, Conjugated (USP); Female; Humans; Lipid Metabolism; Male; Nitric Oxide; Nitric Oxide Synthase; Risk Factors; Selective Estrogen Receptor Modulators | 2003 |
Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Arginine; Biomarkers; Chromatography, High Pressure Liquid; Coronary Disease; Death, Sudden, Cardiac; Female; Follow-Up Studies; Humans; Male; Multivariate Analysis; Myocardial Infarction; Nitric Oxide Synthase; Prospective Studies; Risk Factors; Survival Analysis | 2003 |
Asymmetric dimethylarginine produces vascular lesions in endothelial nitric oxide synthase-deficient mice: involvement of renin-angiotensin system and oxidative stress.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Coronary Disease; Enzyme Induction; Homocysteine; Imidazoles; Infusion Pumps, Implantable; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microcirculation; Myocardium; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitrites; Olmesartan Medoxomil; omega-N-Methylarginine; Oxidative Stress; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Superoxides; Tetrazoles; Thiazepines | 2004 |
Serum homocysteine and endothelial dysfunction in circulatory disorders in women.
Topics: Arginine; Coronary Disease; Endothelium, Vascular; Female; Homocysteine; Humans; Hyperhomocysteinemia; Middle Aged; Myocardial Infarction; Nitric Oxide; Risk; Risk Factors | 2004 |
Relationship between obesity, smoking, and the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine.
Topics: Aged; Arginine; Arteriosclerosis; Coronary Disease; Cross-Sectional Studies; Enzyme Inhibitors; Humans; Insulin Resistance; Male; Metabolic Diseases; Middle Aged; Nitric Oxide Synthase; Obesity; Risk Factors; Smoking | 2004 |
Relations between plasma asymmetric dimethylarginine (ADMA) and risk factors for coronary disease.
Topics: Adult; Aged; Arginine; Biomarkers; Chromatography, High Pressure Liquid; Coronary Angiography; Coronary Disease; Disease Progression; Female; Follow-Up Studies; Glomerular Filtration Rate; Homocysteine; Humans; Male; Middle Aged; Nitric Oxide Synthase; Prognosis; Retrospective Studies; Risk Factors; Smoking | 2006 |
Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study.
Topics: Adult; Aged; Arginine; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Coronary Disease; Creatinine; Female; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Prospective Studies; Risk Factors | 2005 |
Asymmetric dimethylarginine is an independent risk factor for coronary heart disease: results from the multicenter Coronary Artery Risk Determination investigating the Influence of ADMA Concentration (CARDIAC) study.
Topics: Aged; Arginine; Case-Control Studies; Coronary Disease; Female; Humans; Male; Middle Aged; Risk Factors | 2006 |
Asymmetric dimethylarginine, cortisol/cortisone ratio, and C-peptide: markers for diabetes and cardiovascular risk?
Topics: Arginine; Biomarkers; Blood Glucose; C-Peptide; Case-Control Studies; Coronary Disease; Cortisone; Diabetes Mellitus; Female; Humans; Hydrocortisone; Hyperinsulinism; Logistic Models; Male; Middle Aged; Myocardial Infarction; Nitric Oxide Synthase; Predictive Value of Tests; Risk Assessment | 2007 |
Asymmetrical dimethylarginine independently predicts total and cardiovascular mortality in individuals with angiographic coronary artery disease (the Ludwigshafen Risk and Cardiovascular Health study).
Topics: Analysis of Variance; Arginine; Biomarkers; Cardiovascular Diseases; Coronary Angiography; Coronary Disease; Female; Humans; Male; Middle Aged; Mortality; Predictive Value of Tests; Regression Analysis; Risk Factors | 2007 |
Asymmetric dimethylarginine, smoking, and risk of coronary heart disease in apparently healthy men: prospective analysis from the population-based Monitoring of Trends and Determinants in Cardiovascular Disease/Kooperative Gesundheitsforschung in der Regi
Topics: Adult; Aged; Arginine; Case-Control Studies; Cell Line; Coronary Disease; Endothelium, Vascular; Female; Humans; Male; Mass Screening; Middle Aged; Nitric Oxide Synthase; Plasma; Prospective Studies; Risk; Smoking | 2007 |
Asymmetric dimethylarginine is a marker of poor prognosis and coronary calcium in systemic lupus erythematosus.
Topics: Adult; Antibodies, Antinuclear; Arginine; Biomarkers; Calcinosis; Coronary Angiography; Coronary Disease; Ethnicity; Female; Humans; Lipids; Lupus Erythematosus, Systemic; Male; Maryland; Prognosis; Risk Factors | 2007 |